{"SPADE_UN_00699": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2005/0049182 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2005_0049182_A1", "Patent Type": "Patent Application", "Publication Date": "2005-3-3", "Family Info": "CA2456477A1,DE60239707D1,EP1469876A2,EP1469876B1,US6835536,US8138144,US20030171281,US20120202735,WO2003015809A2,WO2003015809A3,WO2003015809A", "Patent Title": "Antimicrobial cationic peptides and formulations thereof.", "Abstract": "Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."}, {"Patent No": "US 6835536 B2", "Patent Link": "http://www.lens.org/lens/patent/US_6835536_B2", "Patent Type": "Granted Patent", "Publication Date": "2004-12-28", "Family Info": "US4510132,US6503881,US6538106,EP590070,WO9112815,WO0000214,WO0071175", "Patent Title": "Antimicrobial Cationic Peptides And Formulations Thereof", "Abstract": "Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganismcaused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."}], "Sequence Information": {"SPADE ID": "SPADE_UN_00699", "Peptide Name": "CP203", "Source": "Synthetic construct", "Family": "Derived from the peptide CP26, CP29, CEME and CEMA", "Gene": "Not found", "Sequence": "KWKSFIKKLTSAAKKVLTTGLPALIS", "Sequence Length": 26, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram-"], "Target Organism": "Gram-negative bacteria:Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=5 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H374 (MIC=4 μg/ml), Pseudomonas aeruginosa H547 (MIC=8 μg/ml).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Lipopolysaccharide (LPS)-binding", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C134H229N33O33", "Mass": 2830.45, "PI": 10.7, "Net Charge": 6, "Hydrophobicity": 0.22, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against Gram-negative bacteria.", "Literature": [{"Title": "Biological properties of structurally related alpha-helical cationic antimicrobial peptides.", "Pubmed ID": "10085049", "Reference": "Infect Immun. 1999 Apr;67(4)2005-2009.", "Author": "Scott MG, Yan H, Hancock RE.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=10085049"}], "Frequent Amino Acids": "KLA", "Absent Amino Acids": "CDEHMNOQRUY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 13, "Polar Residues": 16, "Positive Residues": 6, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_00932", "Similarity": 1.0, "Sequence": "KWKSFIKK"}, {"SPADE_ID": "SPADE_UN_24683", "Similarity": 1.0, "Sequence": "KWKWKRRRFKWKWK"}, {"SPADE_ID": "SPADE_UN_27003", "Similarity": 1.0, "Sequence": "KWKWKPGKWKWK"}]}}}